Literature DB >> 3571453

Bacteriologic and clinical study of Bacteroides oris and Bacteroides buccae.

B L Johnston, M A Edelstein, E Y Holloway, S M Finegold.   

Abstract

We characterized clinical isolates previously identified in our laboratory as Bacteroides ruminicola, the human strains of which are now classified as Bacteroides oris and Bacteroides buccae. A total of 72 isolates (55 B. buccae isolates and 17 B. oris isolates) recovered over a 10-year period were studied. They were differentiated from each other by special-potency antibiotic disks and the RapID-ANA system. The two organisms were associated with a variety of infections, the majority being pleuropulmonary (29.2%) and infections of the head and neck region (27.8%). The infections were always polymicrobial, usually with more than five organisms per specimen. A total of 44% of the B. oris strains and 27% of the B. buccae strains were resistant to penicillin G (breakpoint, 2 U/ml), and this correlated with the presence of beta-lactamase. Although B. oris and B. buccae are found with some frequency in human infections, they are present primarily as components of a mixed flora.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571453      PMCID: PMC265962          DOI: 10.1128/jcm.25.3.491-493.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Bacteroides ruminicola n. sp. and Succinimonas amylolytica; the new genus and species; species of succinic acid-producing anaerobic bacteria of the bovine rumen.

Authors:  M P BRYANT; N SMALL; C BOUMA; H CHU
Journal:  J Bacteriol       Date:  1958-07       Impact factor: 3.490

2.  Bacterial study of pyogenic infections of dental origin.

Authors:  C B Sabiston; W R Grigsby; N Segerstrom
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1976-04

3.  Fecal microbial flora in Seventh Day Adventist populations and control subjects.

Authors:  S M Finegold; V L Sutter; P T Sugihara; H A Elder; S M Lehmann; R L Phillips
Journal:  Am J Clin Nutr       Date:  1977-11       Impact factor: 7.045

4.  Effect of diet on human fecal flora: comparison of Japanese and American diets.

Authors:  S M Finegold; H R Attebery; V L Sutter
Journal:  Am J Clin Nutr       Date:  1974-12       Impact factor: 7.045

5.  Bacteriology of severe periodontitis in young adult humans.

Authors:  W E Moore; L V Holdeman; R M Smibert; D E Hash; J A Burmeister; R R Ranney
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

6.  Clindamycin in treatment of aspiration pneumonia in children.

Authors:  I Brook
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

Review 7.  Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species.

Authors:  B D Kirby; W L George; V L Sutter; D M Citron; S M Finegold
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

8.  Bacterial colonization, tracheobronchitis, and pneumonia following tracheostomy and long-term intubation in pediatric patients.

Authors:  I Brook
Journal:  Chest       Date:  1979-10       Impact factor: 9.410

9.  Use of the RapID-ANA System to screen for enzyme activities that differ among species of bile-inhibited Bacteroides.

Authors:  C A Dellinger; L V Moore
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

  9 in total
  3 in total

Review 1.  Newly recovered and delineated microbial species of the human genital tract.

Authors:  R Hammann
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

2.  Clinical evaluation of the Vitek ANI card for identification of anaerobic bacteria.

Authors:  P C Schreckenberger; D M Celig; W M Janda
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

Review 3.  Newly delineated periodontal pathogens with special reference to selenomonas species.

Authors:  A Tanner; H D Bouldin; M F Maiden
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.